Next-Gen Oral Therapies Reshaping Psoriasis Care

Drs Steven Feldman and Tina Bhutani-Jacques explore how next-generation oral therapies are closing the gap with biologics and reshaping psoriasis care.

Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/ca8/p04/podcast-psoriasis-s4-ep2-2026a10006a5. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

Resources

Acitretin Revisited in the Era of Biologics https://pubmed.ncbi.nlm.nih.gov/20673152/

Apremilast in Psoriasis: Current Landscape and Perspectives https://pubmed.ncbi.nlm.nih.gov/40739686/

Deucravacitinib Versus Placebo and Apremilast in Moderate-to-Severe Plaque Psoriasis: Efficacy and Safety Results From the 52-Week, Randomized, Double-Blinded, Placebo-Controlled Phase 3 POETYK PSO-1 Trial https://pubmed.ncbi.nlm.nih.gov/35820547/

Apremilast Prescribing Information https://www.pi.amgen.com/-/media/Project/Amgen/Repository/pi-amgen-com/Otezla/otezla_pi_english.pdf

Deucravacitinib Prescribing Information https://packageinserts.bms.com/pi/pi_sotyktu.pdf

Tyrosine Kinase 2 Inhibition With Zasocitinib (TAK-279) in Psoriasis: A Randomized Clinical Trial https://pubmed.ncbi.nlm.nih.gov/39167366/

Emerging Oral Therapies for the Treatment of Psoriasis: A Review of Pipeline Agents https://pubmed.ncbi.nlm.nih.gov/38258121/

Oral Icotrokinra for Plaque Psoriasis in Adults and Adolescents https://pubmed.ncbi.nlm.nih.gov/41191940/

National Psoriasis Foundation https://www.psoriasis.org/

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(23)

Can AI Cut Your Psoriasis Admin Hours in Half?

Dr Faranak Kamangar joins Dr Steven Feldman to discuss how AI tools are cutting psoriasis admin hours, improving diagnostic accuracy, and freeing clinicians for more patient-facing care. Relevant disc...

25 Jun 20min

How Confident Should We Be in Psoriasis Biosimilars?

Join Drs Steven Feldman and Jonathan Kay as they examine the data on safety, switching, and confidence in psoriasis biosimilars. Relevant disclosures can be found with the episode show notes on Medsca...

27 Mai 20min

How Much Monitoring Is Enough in Psoriasis Care?

Dr Steven Feldman joins Drs Jennifer Cather and Brad Glick to discuss how much monitoring systemic psoriasis treatments really require in modern practice. Relevant disclosures can be found with the ep...

23 Apr 22min

Can Fixing Adherence Fix Psoriasis Outcomes?

Join Drs Steven Feldman and Bernard Vrijens as they discuss the theory and practice of improving treatment adherence for better patient outcomes in psoriasis. Relevant disclosures can be found with th...

25 Mar 26min

Creams, Foams, and New Formulations: Rethinking Topical Therapy for Psoriasis

From polyaphron technology to fixed combinations, new formulations improve tolerability, adherence, and patient satisfaction. Join Drs Feldman and Armstrong as they discuss. Relevant disclosures can b...

16 Jul 202520min

Smartphones and the Future of Psoriasis Care

Join Drs Steve Feldman and Alexis Ogdie as they explore digital tools that detect and monitor psoriasis and psoriatic arthritis — using only a smartphone, movement, and a few taps. Relevant disclosure...

17 Jun 202521min

What's New in Psoriasis? Dermasphere Podcasters Weigh In

Dr Feldman is joined by Drs Luke Johnson and Michelle Tarbox of the popular podcast Dermasphere, to discuss trends and hot topics in psoriasis. Relevant disclosures can be found with the episode show ...

15 Mai 202523min